These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 21545366)

  • 41. The effects of angiogenic growth factors on extravillous trophoblast invasion and motility.
    Lash GE; Cartwright JE; Whitley GS; Trew AJ; Baker PN
    Placenta; 1999 Nov; 20(8):661-7. PubMed ID: 10527820
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antiphospholipid antibodies and the placenta: a systematic review of their in vitro effects and modulation by treatment.
    Tong M; Viall CA; Chamley LW
    Hum Reprod Update; 2015; 21(1):97-118. PubMed ID: 25228006
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dysregulation of anti-angiogenic agents (sFlt-1, PLGF, and sEndoglin) in preeclampsia--a step forward but not the definitive answer.
    Foidart JM; Schaaps JP; Chantraine F; Munaut C; Lorquet S
    J Reprod Immunol; 2009 Nov; 82(2):106-11. PubMed ID: 19853925
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antiphospholipid antibody-induced trophoblast responses are differentially modulated by viral dsRNA and viral ssRNA.
    DeSpenza RA; Jones DM; Chamley LW; Abrahams VM
    Am J Reprod Immunol; 2022 Feb; 87(2):e13516. PubMed ID: 34904767
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lymphokine-activated killer cells induced from decidual lymphocytes reduce the angiogenic activity of trophoblasts by enhancing the release of soluble fms-like tyrosine kinase-1 from trophoblasts: an implication for the pathophysiology of preeclampsia.
    Matsubara K; Nagamatsu T; Fujii T; Kozuma S; Taketani Y
    J Reprod Immunol; 2005 Dec; 68(1-2):27-37. PubMed ID: 16229897
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Thrombin enhances soluble Fms-like tyrosine kinase 1 expression in trophoblasts; possible involvement in the pathogenesis of preeclampsia.
    Zhao Y; Koga K; Osuga Y; Nagai M; Izumi G; Takamura M; Harada M; Hirota Y; Yoshino O; Taketani Y
    Fertil Steril; 2012 Oct; 98(4):917-21. PubMed ID: 22819145
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Modulation of low molecular weight heparin and heparin-binding epidermal growth factor on biological functions of human first trimester trophoblast].
    Wu XX; Chen Y; Tan JP; Liu ML; Zhang JP
    Zhonghua Fu Chan Ke Za Zhi; 2013 Feb; 48(2):107-12. PubMed ID: 23544491
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against β2 -glycoprotein i domain 1 and domain 4/5: ratio of anti-domain 1 to anti-domain 4/5 as a useful new biomarker for antiphospholipid syndrome.
    Andreoli L; Chighizola CB; Nalli C; Gerosa M; Borghi MO; Pregnolato F; Grossi C; Zanola A; Allegri F; Norman GL; Mahler M; Meroni PL; Tincani A
    Arthritis Rheumatol; 2015 May; 67(8):2196-204. PubMed ID: 25939498
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Low molecular weight heparin therapy during pregnancy is associated with elevated circulatory levels of placental growth factor.
    Yinon Y; Ben Meir E; Margolis L; Lipitz S; Schiff E; Mazaki-Tovi S; Simchen MJ
    Placenta; 2015 Feb; 36(2):121-4. PubMed ID: 25555501
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The efficacy of specific IVIG anti-idiotypic antibodies in antiphospholipid syndrome (APS): trophoblast invasiveness and APS animal model.
    Blank M; Anafi L; Zandman-Goddard G; Krause I; Goldman S; Shalev E; Cervera R; Font J; Fridkin M; Thiesen HJ; Shoenfeld Y
    Int Immunol; 2007 Jul; 19(7):857-65. PubMed ID: 17576752
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunoglobulins from sera of antiphospholipid syndrome patients are internalized in the HTR-8/SVneo cell line and cytotrophoblast in culture.
    Jovanović Krivokuća M; Stefanoska I; Abu Rabi T; Marković M; Janković S; Vrzić-Petronijević S; Vićovac L
    Immunobiology; 2018 Oct; 223(10):544-548. PubMed ID: 29960807
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antiphospholipid antibodies and extracellular vesicles in pregnancy.
    Tong M; Tsai BW; Chamley LW
    Am J Reprod Immunol; 2021 Feb; 85(2):e13312. PubMed ID: 32715546
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Triple Antiphospholipid (aPL) Antibodies Positivity Is Associated With Pregnancy Complications in aPL Carriers: A Multicenter Study on 62 Pregnancies.
    Lazzaroni MG; Fredi M; Andreoli L; Chighizola CB; Del Ross T; Gerosa M; Kuzenko A; Raimondo MG; Lojacono A; Ramazzotto F; Zatti S; Trespidi L; Meroni PL; Pengo V; Ruffatti A; Tincani A
    Front Immunol; 2019; 10():1948. PubMed ID: 31475009
    [No Abstract]   [Full Text] [Related]  

  • 54. Antiphospholipid antibodies and the antiphospholipid syndrome: pathogenic mechanisms.
    Pierangeli SS; Chen PP; Raschi E; Scurati S; Grossi C; Borghi MO; Palomo I; Harris EN; Meroni PL
    Semin Thromb Hemost; 2008 Apr; 34(3):236-50. PubMed ID: 18720303
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Heparin and low-dose aspirin restore placental human chorionic gonadotrophin secretion abolished by antiphospholipid antibody-containing sera.
    Di Simone N; Ferrazzani S; Castellani R; De Carolis S; Mancuso S; Caruso A
    Hum Reprod; 1997 Sep; 12(9):2061-5. PubMed ID: 9363730
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of anti-β2-glycoprotein I antibody on PlGF, VEGF and sVEGFR1 production from cultured choriocarcinoma cell line.
    Ichikawa G; Yamamoto T; Chishima F; Nakamura A; Kuno S; Murase T; Suzuki M
    J Obstet Gynaecol Res; 2011 Aug; 37(8):1076-83. PubMed ID: 21501325
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate.
    Romero R; Nien JK; Espinoza J; Todem D; Fu W; Chung H; Kusanovic JP; Gotsch F; Erez O; Mazaki-Tovi S; Gomez R; Edwin S; Chaiworapongsa T; Levine RJ; Karumanchi SA
    J Matern Fetal Neonatal Med; 2008 Jan; 21(1):9-23. PubMed ID: 18175241
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Angiogenic Imbalance as a Contributor of Preeclampsia.
    Dymara-Konopka W; Laskowska M; Błażewicz A
    Curr Pharm Biotechnol; 2018; 19(10):797-815. PubMed ID: 30255753
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Melatonin enhances antioxidant molecules in the placenta, reduces secretion of soluble fms-like tyrosine kinase 1 (sFLT) from primary trophoblast but does not rescue endothelial dysfunction: An evaluation of its potential to treat preeclampsia.
    Hannan NJ; Binder NK; Beard S; Nguyen TV; Kaitu'u-Lino TJ; Tong S
    PLoS One; 2018; 13(4):e0187082. PubMed ID: 29641523
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sulfasalazine reduces placental secretion of antiangiogenic factors, up-regulates the secretion of placental growth factor and rescues endothelial dysfunction.
    Brownfoot FC; Hannan NJ; Cannon P; Nguyen V; Hastie R; Parry LJ; Senadheera S; Tuohey L; Tong S; Kaitu'u-Lino TJ
    EBioMedicine; 2019 Mar; 41():636-648. PubMed ID: 30824385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.